Диссертация (1140388), страница 22
Текст из файла (страница 22)
The continuing story of class IIa bacteriocins / D. Drider, G. Fimland, Y.Hechard, H.L.M. McMullen // Prevost Microbiol. Mol. Biol. ReV. – 2006. – V.70. – P. 564-582.207. The diversity of bacteriocins in Gram-positive bacteria / N.C.K. Heng, P. A.Wescombe , J.P.Burton , R.W. Jack , J.R. Tagg, editors: M.A. Riley,M. Chavan // Bacteriocins: ecology and evolution. –Springer. – Berlin. – 2007. –P. 45–92.208. The mode of action of the lantibiotic lacticin 3147—A complex mechanisminvolving specific interaction of two peptides and the cell wall precursor lipid II / I.Wiedemann, T. Bottiger, R.R.
Bonelli, et al. // Mol. Microbiol. – 2006. – V. 61. –P. 285-296.209. The neutrophil as a cellular source of chemokines / P. Scapini, J.A. Lapinet-Vera,S. Gasperini, et. al. // Immunol. ReV. – 2000. – V. 177. – P. 195-203.210. The pathogenesis of catheter-related bloodstream infection with noncuffed shortterm central venous catheters / N. Safdar, et al.
// Inten. Care Med. – 2004. – V.30. – P. 62-67.141211. The role of sigma (B) in persistence of Staphylococcus epidermidis foreign bodyinfection / V. Pintens, et al. // Microbiology. – 2008. – V. 154. – P. 2827-2836.212. The structure and function of mammalian membrane-attack complex/perforinlike proteins / S.C. Kondos, T. Hatfaludi, I.
Voskoboinik, et al. // Tissue Antigens.– 2010. – V. 76, №5. – P. 341-351.213. Treatment and prevention of Candida albicans biofilms with caspofungin in anovel central venous catheter murine model of candidiasis / A.L. Lazzell, et al. //J. Antimicrob. Chemother. – 2009. – V. 64. – P. 567–570.214. Turnbull, A.V. Regulation of the hypothalamic-pitituitary-adrenal axis bycytokines: actions and mechanism of action / A.V. Turnbull, C.L.Rivier //Physiol.
Rev. – 1999. – V. 79 (1). – P. 1-71.215. Type II restriction endonuclease R.Eco29kI is a member of the GIY-YIGnuclease superfamily / M.V. Zakharova, I.V. Beletskaya, D.V. Bolovin, et al. //Mol. Genet. Genomics. – 2003. – V. 270. – P. 415-419.216. Vaara, M. New approaches in peptide antibiotics / M. Vaara // Curr. Opin.Pharmacol. – 2009. – V. 9. – P. 571–576.217. Veenstra, D. Efficacy of anticeptic-impregnated central venous catheters inpreventing catheter-related bloodstream infection / D. Veenstra, S. Saint, S. Saha// JAMA.
–1999. – Vol. 281. – P. 261-267.218. Vives, E. Cell-penetrating and cell-targeting peptides in drug delivery / E. Vives// Biochim. Biophys. Acta. ReV. Cancer. – 2008. – V. 1786. – P. 126–138.219. Walder B., Pittet D. Prevention of bloodstream infections with central venouscatheters treated with anti-infective agents depends on catheter type and insertiontime: evidence from a meta-analysis / B. Walder, D. Pittet // Infect. Control HosP.Epidemiol. – 2002. – Vol. 23. – P. 748-756.220. Warren, D. Nosocomial primary bloodstream infections in intensive care unitpatients in a nonteaching community medical center: a 21-month prospective study/ D.
Warren, J. Zack, A. Elward // Clin. Infect. Dis. – 2001. – Vol. 33. – P. 1329-1335.142221. Weibel, E.R. Practical Methods for Biological Morphometry / E.R. Weibel //Academic Press. – London. – 1979. – P. 402.222. Wimley, W. C. Describing the mechanism of antimicrobial peptide action withthe interfacial activity model / W.C. Wimley // ACS Chem. Biol.
– 2010. – V. 5. –P. 905–917.223. Wuepper, K.D. Studies of the mechanism of epidermal injury by aStaphylococcal epidermolytic toxin / K.D. Wuepper, R.L. Dimond, D.D. Knutson// J. Invest. Dermatol. – 1975. – V. 65. – P. 191-200.224. Zasloff, M. Antimicrobial peptides of multicellular organisms / M. Zasloff //Nature. – 2002.
– V. 415, №6870. – P. 389-395..















